Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07157943 · ClinicalTrials.gov registry record · NA

Comparison of Two Artificial Intelligence Scribe Products on Pediatric Subspecialty Provider Wellness and Experience, Patient Satisfaction, and Efficiency.

A NA study of Burnout, sponsored by Children's Healthcare of Atlanta.

Active
Registry status
NA
Development phase
105
Enrollment target
1
Study location

NCT07157943: Active NA study of Burnout, sponsored by Children's Healthcare of Atlanta.

NCT07157943 is a NA study of Burnout that is active but no longer recruiting, run by Children's Healthcare of Atlanta. The registered enrollment target is 105 participants, below the 5,153-participant average among 18 other Burnout trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07157943, a NA study of Burnout, is active but no longer recruiting, sponsored by Children's Healthcare of Atlanta.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

The goal of this rapid, randomized quality improvement trial is to learn if implementing generative AI scribe software can enhance physician documentation efficiency and reduce burnout in outpatient providers at Children's Healthcare of Atlanta facilities. The main questions it aims to answer are: * Do AI scribes have significant benefits in terms of physician burnout, clinical efficiency, patient experience, and business efficiency? * Does one vendor outperform another in these measures? The investigators will compare providers using DAX Copilot and Abridge AI scribe software to a control group using traditional documentation methods to see if AI scribes improve documentation efficiency and reduce burnout. Participants will: * Be randomized to one of two AI scribe vendors or control * Intervention participants may be crossed over to the other vendor mid-trial. * Collect patient experience scores pre- and post-intervention * Complete surveys on burnout, efficiency, and fulfillment.

Primary Outcome

The average number of minutes per scheduled day spent in charting activities outside 7 AM to 5:30 PM on weekdays, time outside scheduled hours on weekends, and time on unscheduled holidays

Conditions Studied

Interventions

  • OTHER Abridge AI Scribe
  • OTHER DAX Copilot

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2025-04-14
Est. Completion 2025-09-12
Phase NA
Children's Healthcare of Atlanta

80 total trials

What the registry record for NCT07157943 still lists

NCT07157943 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 5,153-participant average among 18 other Burnout trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Burnout appearing as the primary indexed condition, and to 2 interventions - of which Abridge AI Scribe is the first listed.

NCT07157943 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT07157943 about?

NCT07157943 is a clinical study titled "Comparison of Two Artificial Intelligence Scribe Products on Pediatric Subspecialty Provider Wellness and Experience, Patient Satisfaction, and Efficiency.". The goal of this rapid, randomized quality improvement trial is to learn if implementing generative AI scribe software can enhance physician documentation efficiency and reduce burnout in outpatient providers at Children's Healthcare of Atlanta facilities. The main questions it aims to answer are: ...

What is the current status of trial NCT07157943?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2025-04-14. Estimated completion is 2025-09-12.

What conditions does trial NCT07157943 study?

This clinical trial studies the following conditions: Burnout.

What interventions are being tested in trial NCT07157943?

The interventions under investigation include: Abridge AI Scribe (OTHER), DAX Copilot (OTHER).

Who is sponsoring clinical trial NCT07157943?

This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07157943 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Burnout

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07157943's enrollment target sits among peer trials

105 10th of 18 higher than 9 of 18 other Burnout trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Burnout trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07157943, the US trial registry maintained by the National Library of Medicine. NCT07157943 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.